Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Hypertension - Part A Theory and Practice
Clinical and Experimental Hypertension - Part A Theory and Practice is not currently indexed in Scopus. Published by Marcel Dekker Inc..
ISSN 0730-0077Verify ISSN ↗
Publisher: Marcel Dekker Inc.
Cost to publish: No APC data — check the publisher
Is Clinical and Experimental Hypertension - Part A Theory and Practice indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1982–1992).
What is the impact factor of Clinical and Experimental Hypertension - Part A Theory and Practice? Clinical and Experimental Hypertension - Part A Theory and Practice has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Is Clinical and Experimental Hypertension - Part A Theory and Practice in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Clinical and Experimental Hypertension - Part A Theory and Practice open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
Impact & reach — open metrics via OpenAlex
Clinical and Experimental Hypertension - Part A Theory and Practice published 52 papers in 2025; its busiest recent year was 2017 with 190. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.
Who publishes here — latest 99 articles, 2024–2026
In its latest 99 research articles (2024–2026), authors are most often from China (77.8%), Türkiye (3.9%) and Japan (3%). More than half of recent authorship comes from one country. Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Integrity signals — indicators, not proof of misconduct
- Scopus statusInactive — coverage ended 1992
- Retracted papers 2 · 0.4 per 1,000 papers
- Author concentration77.8% of recent authorship from China
Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.
Official sources & links
Related journals
- Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy
- Clinical immunology reviews
- Clinical Research Practices and Drug Regulatory Affairs
- DRUG DEV.COMMUN.
- Electro- and Magnetobiology
- Electroanalytical Chemistry
- Endocrine Research Communications
- Fuel Science and Technology International
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.